Empower Advisory Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $317K | Sell |
6,840
-1,528
| -18% | -$70.7K | ﹤0.01% | 397 |
|
|
2025
Q1 | $510K | Buy |
8,368
+204
| +2% | +$12.4K | ﹤0.01% | 320 |
|
|
2024
Q4 | $462K | Sell |
8,164
-15
| -0.2% | -$848 | ﹤0.01% | 335 |
|
|
2024
Q3 | $423K | Sell |
8,179
-1,095
| -12% | -$56.7K | ﹤0.01% | 340 |
|
|
2024
Q2 | $385K | Sell |
9,274
-1,244
| -12% | -$51.7K | ﹤0.01% | 346 |
|
|
2024
Q1 | $570K | Sell |
10,518
-577
| -5% | -$31.3K | ﹤0.01% | 286 |
|
|
2023
Q4 | $569K | Buy |
11,095
+1,201
| +12% | +$61.6K | ﹤0.01% | 287 |
|
|
2023
Q3 | $574K | Sell |
9,894
-1,051
| -10% | -$61K | ﹤0.01% | 280 |
|
|
2023
Q2 | $700K | Buy |
10,945
+240
| +2% | +$15.3K | ﹤0.01% | 265 |
|
|
2023
Q1 | $746K | Buy |
+10,705
| New | +$746K | ﹤0.01% | 262 |
|